279 related articles for article (PubMed ID: 17545617)
1. Localization of human TACC3 to mitotic spindles is mediated by phosphorylation on Ser558 by Aurora A: a novel pharmacodynamic method for measuring Aurora A activity.
LeRoy PJ; Hunter JJ; Hoar KM; Burke KE; Shinde V; Ruan J; Bowman D; Galvin K; Ecsedy JA
Cancer Res; 2007 Jun; 67(11):5362-70. PubMed ID: 17545617
[TBL] [Abstract][Full Text] [Related]
2. A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells.
Fielding AB; Lim S; Montgomery K; Dobreva I; Dedhar S
Oncogene; 2011 Feb; 30(5):521-34. PubMed ID: 20838383
[TBL] [Abstract][Full Text] [Related]
3. MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy.
Hoar K; Chakravarty A; Rabino C; Wysong D; Bowman D; Roy N; Ecsedy JA
Mol Cell Biol; 2007 Jun; 27(12):4513-25. PubMed ID: 17438137
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase.
Manfredi MG; Ecsedy JA; Meetze KA; Balani SK; Burenkova O; Chen W; Galvin KM; Hoar KM; Huck JJ; LeRoy PJ; Ray ET; Sells TB; Stringer B; Stroud SG; Vos TJ; Weatherhead GS; Wysong DR; Zhang M; Bolen JB; Claiborne CF
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4106-11. PubMed ID: 17360485
[TBL] [Abstract][Full Text] [Related]
5. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
Huck JJ; Zhang M; McDonald A; Bowman D; Hoar KM; Stringer B; Ecsedy J; Manfredi MG; Hyer ML
Mol Cancer Res; 2010 Mar; 8(3):373-84. PubMed ID: 20197380
[TBL] [Abstract][Full Text] [Related]
6. ASAP is a novel substrate of the oncogenic mitotic kinase Aurora-A: phosphorylation on Ser625 is essential to spindle formation and mitosis.
Venoux M; Basbous J; Berthenet C; Prigent C; Fernandez A; Lamb NJ; Rouquier S
Hum Mol Genet; 2008 Jan; 17(2):215-24. PubMed ID: 17925329
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays.
Manfredi MG; Ecsedy JA; Chakravarty A; Silverman L; Zhang M; Hoar KM; Stroud SG; Chen W; Shinde V; Huck JJ; Wysong DR; Janowick DA; Hyer ML; Leroy PJ; Gershman RE; Silva MD; Germanos MS; Bolen JB; Claiborne CF; Sells TB
Clin Cancer Res; 2011 Dec; 17(24):7614-24. PubMed ID: 22016509
[TBL] [Abstract][Full Text] [Related]
8. Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.
Chakravarty A; Shinde V; Tabernero J; Cervantes A; Cohen RB; Dees EC; Burris H; Infante JR; Macarulla T; Elez E; Andreu J; Rodriguez-Braun E; Rosello S; von Mehren M; Meropol NJ; Langer CJ; ONeil B; Bowman D; Zhang M; Danaee H; Faron-Yowe L; Gray G; Liu H; Pappas J; Silverman L; Simpson C; Stringer B; Tirrell S; Veiby OP; Venkatakrishnan K; Galvin K; Manfredi M; Ecsedy JA
Cancer Res; 2011 Feb; 71(3):675-85. PubMed ID: 21148750
[TBL] [Abstract][Full Text] [Related]
9. Trivalent dimethylarsenic compound induces histone H3 phosphorylation and abnormal localization of Aurora B kinase in HepG2 cells.
Suzuki T; Miyazaki K; Kita K; Ochi T
Toxicol Appl Pharmacol; 2009 Dec; 241(3):275-82. PubMed ID: 19716834
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic abrogation of the mitotic spindle checkpoint by an indolocarbazole discovered by cellular screening efficiently kills cancer cells.
Stolz A; Vogel C; Schneider V; Ertych N; Kienitz A; Yu H; Bastians H
Cancer Res; 2009 May; 69(9):3874-83. PubMed ID: 19366805
[TBL] [Abstract][Full Text] [Related]
11. Clathrin heavy chain mediates TACC3 targeting to mitotic spindles to ensure spindle stability.
Lin CH; Hu CK; Shih HM
J Cell Biol; 2010 Jun; 189(7):1097-105. PubMed ID: 20566684
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer.
Wunderlich A; Fischer M; Schlosshauer T; Ramaswamy A; Greene BH; Brendel C; Doll D; Bartsch D; Hoffmann S
Cancer Sci; 2011 Apr; 102(4):762-8. PubMed ID: 21214672
[TBL] [Abstract][Full Text] [Related]
13. Validating Aurora B as an anti-cancer drug target.
Girdler F; Gascoigne KE; Eyers PA; Hartmuth S; Crafter C; Foote KM; Keen NJ; Taylor SS
J Cell Sci; 2006 Sep; 119(Pt 17):3664-75. PubMed ID: 16912073
[TBL] [Abstract][Full Text] [Related]
14. Aurora-A: the maker and breaker of spindle poles.
Barr AR; Gergely F
J Cell Sci; 2007 Sep; 120(Pt 17):2987-96. PubMed ID: 17715155
[TBL] [Abstract][Full Text] [Related]
15. Aurora A site specific TACC3 phosphorylation regulates astral microtubule assembly by stabilizing γ-tubulin ring complex.
Rajeev R; Singh P; Asmita A; Anand U; Manna TK
BMC Mol Cell Biol; 2019 Dec; 20(1):58. PubMed ID: 31823729
[TBL] [Abstract][Full Text] [Related]
16. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.
Kaestner P; Stolz A; Bastians H
Mol Cancer Ther; 2009 Jul; 8(7):2046-56. PubMed ID: 19584233
[TBL] [Abstract][Full Text] [Related]
17. SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo.
Arbitrario JP; Belmont BJ; Evanchik MJ; Flanagan WM; Fucini RV; Hansen SK; Harris SO; Hashash A; Hoch U; Hogan JN; Howlett AR; Jacobs JW; Lam JW; Ritchie SC; Romanowski MJ; Silverman JA; Stockett DE; Teague JN; Zimmerman KM; Taverna P
Cancer Chemother Pharmacol; 2010 Mar; 65(4):707-17. PubMed ID: 19649632
[TBL] [Abstract][Full Text] [Related]
18. Phospho-regulation of human protein kinase Aurora-A: analysis using anti-phospho-Thr288 monoclonal antibodies.
Ohashi S; Sakashita G; Ban R; Nagasawa M; Matsuzaki H; Murata Y; Taniguchi H; Shima H; Furukawa K; Urano T
Oncogene; 2006 Dec; 25(59):7691-702. PubMed ID: 16785988
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of aurora A.
Liu HS; Ke CS; Cheng HC; Huang CY; Su CL
Mol Pharmacol; 2011 Oct; 80(4):638-46. PubMed ID: 21757545
[TBL] [Abstract][Full Text] [Related]
20. A small compound targeting TACC3 revealed its different spatiotemporal contributions for spindle assembly in cancer cells.
Yao R; Kondoh Y; Natsume Y; Yamanaka H; Inoue M; Toki H; Takagi R; Shimizu T; Yamori T; Osada H; Noda T
Oncogene; 2014 Aug; 33(33):4242-52. PubMed ID: 24077290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
